Table 2 Comparison of participant baseline and final measures
Outcome | Baseline (n = 4) | Final# (n = 3) |
|---|---|---|
Weight (kg), median (IQR) | 106 (78–140) | 92 (77–106) |
Body mass index (kg/m2), median (IQR) | 40 (29–54) | 35 (29–40) |
Waist circumference (cm), median (IQR) | 115 (92–133) | 108 (88–115) |
Waist-to-hip ratio, median (IQR) | 0.88 (0.87–0.89) | 0.87 (0.84–0.88) |
Systolic blood pressure (mmHg), median (IQR) | 117 (105–127) | 110 (105–118) |
Diastolic blood pressure (mmHg), median (IQR) | 76 (67–79) | 70 (70–73) |
6-min walk test distance (m), median (IQR) | 518 (290–578) | 386 (246–525) |
MacNew Global (1–7), median (IQR) | 5.6 (5.3–6.3) | 5.8 (5.7–6.0) |
MacNew Physical (1–7), median (IQR) | 5.2 (4.9–6.2) | 6.1 (5.4–6.4) |
MacNew Social (1–7), median (IQR) | 6.0 (5.7–6.5) | 6.2 (6.2–6.4) |
MacNew Emotional (1–7), median (IQR) | 5.8 (5.5–6.5) | 5.7 (5.7–6.0) |
HADS-Anxiety (0–21), median (IQR) | 4.5 (2–7.5) | 6 (3–7) |
HADS-Depression (0–21), median (IQR) | 3 (1.0–7.0) | 2 (1.5–2.5) |
Total cholesterol (mmol/L), median (IQR) | 3.3 (2.9–5.1) | 3.6 (3.4–3.7) |
Triglycerides (mmol/L), median (IQR) | 1.6 (1.1–2.2) | 1.4 (1.1–2.2) |
Low-density lipoprotein (mmol/L), median (IQR) | 1.6 (1.6–2.2) | 1.7 (1.5–2.0) |
High-density lipoprotein (mmol/L), median (IQR) | 0.88 (0.71–1.1) | 0.88 (0.83–1.0) |
Blood glucose level (mmol/L), median (IQR) | 5.3 (5.0–5.6) | 5.1 (4.7–6.2) |